益生菌的安全性
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Safety of probiotics – A Review
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    益生菌是指一类活的, 摄入足够量就能够对人体产生有益作用的微生物, 目前广泛应用于食品发酵、工业乳酸发酵以及医疗保健领域。随着市场上商品化益生菌的不断出现, 它所带来的安全性问题也更加引起人们的关注。目前益生菌主要存在四个方面的安全问题:致病性和感染能力; 有害的代谢活动; 过度的免疫反应和可能的基因转移。传统的益生菌安全性评价方法具有一定的局限性。我们需要针对目前益生菌安全性存在的问题建立一套包含基因组学, 代谢组学, 蛋白质组学等研究内容的评估方法, 对益生菌的安全性进行系统全面的评估。本文总结了一些对于益生菌安全性的研究进展和研究方法, 以提示我国应尽快完善益生菌及其制品的安全性评价方法指标并建立安全性评价体系, 使益生菌更好的为人们的健康服务。

    Abstract:

    Probiotics are live microorganisms. When they were administered in adequate amounts, they could have beneficial effects on the host. They are generally applied in food fermentation, industrial lactic acid production and medical care. With the appearance of commercial probiotics, more concerns were raised on the safety of probiotics. At present, there were four aspects of safety concerns on probiotics: pathogenicity and infectivity; deleterious metabolic activities; excessive immune response and potential gene transfer. Conventional toxicology and safety evaluation has limited value in the safety assessment of probiotics used in marketing food and drugs nowadays. Instead, multidisciplinary approaches are necessary for the systematical safety evaluation of probiotic strains. It may involve genomics, metabolismics, proteomics, among others. The toxigenic metabolic activity should be considered especially. We reviewed recent developments and research methods on the safety of probiotics. Safety evaluation of the lactic acid bacteria for human consumption must be assessed by proposing criteria standards, guidelines and regulations, for better applications for consumers.

    参考文献
    相似文献
    引证文献
引用本文

张灼阳,刘畅,郭晓奎. 益生菌的安全性. 微生物学报, 2008, 48(2): 257-261

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2007-05-24
  • 最后修改日期:2007-10-17
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码